ABSTRACT
The establishment of precise and reliable biomarker tests for the early stages of cardiovascular disease is of great importance and can be the cornerstone in the prevention of future cardiovascular disease (CVD). Furthermore, some biomarkers may provide important information concerning the pathogenesis of CVD or appear to be useful in risk stratifi
TABLE OF CONTENTS
part |2 pages
Part I: Classical Biomarkers
part |2 pages
Part II: Novel Biomarkers